Control was 50mg mannitol twice daily for 52 weeks, as opposed to 400mg twice daily for treatment dose.
Has this contributed to it missing statistical significance? Wasn't this also an issue in the CF trials?
Another case of poor trial design?
Held this stock for 7 years. What a waste of time and money!
- Forums
- ASX - By Stock
- ph 3 trial fails primary endpoint
Control was 50mg mannitol twice daily for 52 weeks, as opposed...
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $54.92M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 3.6¢ | $152.2K | 4.019M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 104121 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 99980 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 104121 | 0.039 |
2 | 218558 | 0.038 |
3 | 590243 | 0.037 |
7 | 702200 | 0.036 |
5 | 985528 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 99980 | 1 |
0.042 | 100000 | 1 |
0.043 | 200000 | 1 |
0.045 | 200000 | 1 |
0.046 | 69660 | 2 |
Last trade - 15.58pm 14/11/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |